LIfT BioSciences
Latest round
- Series A
Last raised
- May 2024
Total raised
- $13M
Investors
- 3
About LIfT BioSciences
Based in London, UK, and founded in 2016, LIfT BioSciences Ltd operates as a provider of biotechnology solutions using alpha neutrophil cell therapy. LIfT BioSciences develops breakthrough cell therapies to treat solid tumors using its own product, Immuno-Modulatory Alpha Neutrophils (IMANs). These treatments work by directly targeting and eliminating cancer cells while also stimulating the immune system to recognize the tumor. The company operates in the United Kingdom and throughout Europe, serving healthcare practitioners and patients. The firm's mission is to meet substantial medical requirements in the treatment of solid tumors. LIfT BioSciences Ltd earns revenue by developing and licensing patented neutrophil-based immuno-oncology cell therapies, partnering for clinical trials, and securing grants plus strategic collaborations.
Who invested in LIfT BioSciences
3 investors across 1 round
See all investors in LIfT BioSciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 7, 2024
Amount
$13M
Investors
Questions about LIfT BioSciences
Who invested in LIfT BioSciences?
LIfT BioSciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LIfT BioSciences raised?
LIfT BioSciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LIfT BioSciences last raise money?
LIfT BioSciences's most recent round on record is a Series A, in May 2024.
What does LIfT BioSciences do?
Based in London, UK, and founded in 2016, LIfT BioSciences Ltd operates as a provider of biotechnology solutions using alpha neutrophil cell therapy.
Where is LIfT BioSciences headquartered?
LIfT BioSciences is headquartered in London, UK.
Which VCs invest in companies like LIfT BioSciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at LIfT BioSciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like LIfT BioSciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.